Genomic Signatures of Pregnancy-Associated Breast Cancer Epithelia and Stroma and their Regulation by Estrogens and Progesterone

Hormones and Cancer

Volumn 4, Issue 3, 2013, Pages 140-153

  Harvell, Djuana M E ^a   Kim, Jihye ^a   O'Brien, Jenean ^a   Tan, Aik Choon ^a   Borges, Virginia F ^a   Schedin, Pepper ^a   Jacobsen, Britta M ^a   Horwitz, Kathryn B ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER RECURRENCE; CELL CYCLE; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MICRODISSECTION; PREGNANCY; PRIORITY JOURNAL; STROMA CELL; TUMOR MICROENVIRONMENT;

ADULT; BREAST NEOPLASMS; EPITHELIUM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGESTERONE; STROMAL CELLS;

EID: 84877052300     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-013-0136-z     Document Type: Article

References (49)

1. Lyons TR, Schedin PJ, Borges VF (2009) Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 14: 87-98.
2. Vinatier E, Merlot B, Poncelet E, Collinet P, Vinatier D (2009) Breast cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol 147: 9-14.
3. Petrek JA (1994) Pregnancy safety after breast cancer. Cancer 74: 528-531.
4. Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12: 888-894.
5. Horwitz KB, McGuire WL (1978) Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253: 8185-8191.
6. Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6: 281-291.
7. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP (2003) Summaries of Affymetrix Genechip probe level data. Nucleic Acids Res 31: e15.
8. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
9. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc 4: 44-57.
10. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25: 25-29.
11. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) Kegg for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-360.
12. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
13. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
14. Sartorius CA, Harvell DM, Shen T, Horwitz KB (2005) Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res 65: 9779-9788.
15. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277: 5209-5218.
16. Harvell DM, Richer JK, Singh M, Spoelstra N, Finlayson C, Borges VF, Elias AD, Horwitz KB (2008) Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: Tamoxifen agonist effects dominate in the presence of an aromatase inhibitor. Breast Cancer Res Treat 112: 489-501.
17. Harvell DM, Richer JK, Allred DC, Sartorius CA, Horwitz KB (2006) Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture. Endocrinology 147: 700-713.
18. Ghatge RP, Jacobsen BM, Schittone SA, Horwitz KB (2005) The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells. Breast Cancer Res 7: R1036-1050.
19. Frasor J, Danes JM, Komm B, Chang KCN, Lyttle CR, Katzenellenbogen BS (2003) Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574.
20. Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, Chinnaiyan AM, Lippman ME, Rae JM (2006) Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol 7: R28.
21. Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, Bernards R, van de Vijver M, Deutsch P, Sachs A, Stoughton R, Friend S (2005) A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res 65: 4059-4066.
22. Durig J, Nuckel H, Huttmann A, Kruse E, Holter T, Halfmeyer K, Fuhrer A, Rudolph R, Kalhori N, Nusch A, Deaglio S, Malavasi F, Moroy T, Klein-Hitpass L, Duhrsen U (2003) Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 101: 2748-2755.
23. Douglas MR, Morrison KE, Salmon M, Buckley CD (2002) Why does inflammation persist: a dominant role for the stromal microenvironment? Expert Rev Mol Med 4: 1-18.
24. Bergamaschi A, Tagliabue E, Sorlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Menard S, Borresen-Dale AL (2008) Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. J Pathol 214: 357-367.
25. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R (2002) Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet 11: 863-872.
26. Porter S, Span PN, Sweep FC, Tjan-Heijnen VC, Pennington CJ, Pedersen TX, Johnsen M, Lund LR, Romer J, Edwards DR (2006) Adamts8 and adamts15 expression predicts survival in human breast carcinoma. Int J Cancer 118: 1241-1247.
27. Nagahara M, Mimori K, Kataoka A, Ishii H, Tanaka F, Nakagawa T, Sato T, Ono S, Sugihara K, Mori M (2010) Correlated expression of cd47 and sirpa in bone marrow and in peripheral blood predicts recurrence in breast cancer patients. Clin Cancer Res 16: 4625-4635.
28. McCready J, Arendt LM, Rudnick JA, Kuperwasser C (2010) The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res 12: 205.
29. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC (2009) Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11: R7.
30. Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB (2009) The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res 15: 778-787.
31. Makiyama K, Hamada J, Takada M, Murakawa K, Takahashi Y, Tada M, Tamoto E, Shindo G, Matsunaga A, Teramoto K, Komuro K, Kondo S, Katoh H, Koike T, Moriuchi T (2005) Aberrant expression of hox genes in human invasive breast carcinoma. Oncol Rep 13: 673-679.
32. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123-139.
33. Asztalos S, Gann PH, Hayes MK, Nonn L, Beam CA, Dai Y, Wiley EL, Tonetti DA (2010) Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila) 3: 301-311.
34. Russo J, Balogh GA, Russo IH (2008) Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17: 51-66.
35. Hsiao YH, Su YA, Tsai HD, Mason JT, Chou MC, Man YG (2010) Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression. Int J Biol Sci 6: 428-442.
36. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423.
37. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner F, Walker M, Watson D, Park T, Hiller W, Fisher E, Wickerham D, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.
38. Yu J, Cordero KE, Johnson MD, Ghosh D, Rae JM, Chinnaiyan AM, Lippman ME (2008) A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Neoplasia 10: 79-88.
39. Xu L, Tan AC, Winslow RL, Geman D (2008) Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinforma 9: 125.
40. Medri L, Volpi A, Nanni O, Vecci AM, Mangia A, Schittulli F, Padovani F, Giunchi DC, Zito A, Amadori D, Paradiso A, Silvestrini R (2003) Prognostic relevance of mitotic activity in patients with node-negative breast cancer. Mod Pathol 16: 1067-1075.
41. Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA (2008) The immune system-is it relevant to cancer development, progression and treatment. Clin Oncol 20: 101-112.
42. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncology reports 14: 425-431.
43. Zhao W, Grubbs CJ, Myers RK, Nilsen-Hamilton M (2010) Parity is associated with an expanded macrophage population in the mammary gland. Int J Oncol 37: 1195-1202.
44. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, Man YG, Borges V, Schedin P (2010) Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 176: 1241-1255.
45. Boneberg EM, Legler DF, Hoefer MM, Ohlschlegel C, Steininger H, Fuzesi L, Beer GM, Dupont-Lampert V, Otto F, Senn HJ, Furstenberger G (2009) Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. Br J Cancer 101: 605-614.
46. Leenders WP, Kusters B, Verrijp K, Maass C, Wesseling P, Heerschap A, Ruiter D, Ryan A, de Waal R (2004) Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res 10: 6222-6230.
47. Ronnov-Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 76: 69-125.
48. Sato Y, Goto Y, Narita N, Hoon DS (2009) Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenviron 2(Suppl 1): 205-214.
49. Ali S, Lazennec G (2007) Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev 26: 401-420.